SYK
Back on its feet
Stryker just reminded Wall Street that medical tech companies can be surprisingly resilient when the operating room keeps humming. The company said it booked $1.28 billion in profit and also reported higher revenue, even as it continues recovering from a March cyberattack.
That matters because cyber incidents can be like tripping over your own shoelaces on the way to a marathon: messy, distracting, and usually expensive. So seeing Stryker still post stronger top-line and bottom-line numbers suggests the recovery effort is doing more than just patching holes.
Why investors should care
The big question here isn’t just whether Stryker can get back to normal — it’s how fast “normal” returns. Investors will be watching for signs that:
- the cyberattack is no longer putting a meaningful dent in operations
- sales momentum is holding up despite the disruption
- the company can keep margins from getting squeezed by recovery costs
The bigger picture
Stryker doesn’t need a flawless quarter to keep the market happy. It just needs to show the outage was a speed bump, not a rerouting of the whole highway. And this update is a decent first clue that the company is moving in that direction.
Big picture: if Stryker can turn a March cyberattack into a temporary bruise instead of a lasting scar, that’s exactly the kind of boring-but-good outcome investors like to see.